The Coca-Cola Company and its three main bottling groups in China – Coca-Cola Bottling Investments Group China (BIG), COFCO Coca-Cola Beverages Limited and Swire Beverages Holdings Limited (Swire) commemorated the completion of a definitive agreement to refranchise all existing company-owned bottling operations in China last month.###The transaction will result in a divide of the Coca-Cola’s bottling system in China between the two franchise partners – COFCO and Swire.###“By refranchising all our Company-owned bottling operations in China to strong local partners, we position these companies to leverage magnesium citrate 150 mggreater scale, capability and efficiency throughout China to investsource naturals calcium citrate for growth and deliver improved kirkland magnesium tabletsservice to customers and consumers in a fast-changing marketplace,” said Muhtar Kent, Chairman and CEO, The Coca-Cola Company.  ###As Coca-Cola’s third-largest market by volume, China represents a significant long-term growth opportunity for The Coca-Cola Company and its bottling system.###The Coca-Cola system in China is currently investing US$4 billion locally for future growth from 2015 to 2017, building on US$9 billioncalcium magnesium citrate with d3 of investments made in the market since 1979. ###In February 2016, The Coca-Cola Company announced a non-binding letter of intent to negotiate the refranchising of its bottling operations with existing partners, COFCO and Swire. ###When the transaction is complete, COFCO will own and operate 18 bottling plants, and Swire will own and operate 17calcium citrate constipation in Mainland China.###The China transaction remains subject to regulatory approvals from relevant government authorities. ###Until the transaction closes, all bottling plants and customer relationships will continue to operate as normal under current bottling ownership.